Atropine Sulfate is a tropane-alkaloid muscarinic receptor antagonist used to treat symptomatic bradycardia, as an antidote for organophosphate and nerve-agent poisoning, as a pre-anaesthetic agent, and to induce mydriasis in ophthalmic examination. Simson Pharma's Atropine Sulfate reference standard and impurities (including its apoatropine degradation product) support the critical-care QC this versatile anticholinergic demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Atropine Sulfate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.